Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_001386795.1(DTNA):c.953C>A(p.Pro318His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
DTNA (HGNC:3057): (dystrobrevin alpha) The protein encoded by this gene belongs to the dystrobrevin subfamily of the dystrophin family. This protein is a component of the dystrophin-associated protein complex (DPC), which consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and alpha- and beta-dystrobrevin. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Mutations in this gene are associated with left ventricular noncompaction with congenital heart defects. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.953C>A (p.P318H) alteration is located in exon 9 (coding exon 8) of the DTNA gene. This alteration results from a C to A substitution at nucleotide position 953, causing the proline (P) at amino acid position 318 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Apr 16, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The Pro318His variant in DTNA has not been previously reported in individuals wi th cardiomyopathy or in large population studies. Computational prediction tool s and conservation analysis suggest that the Pro318His variant may impact the pr otein, though this information is not predictive enough to determine pathogenici ty. In summary, the clinical significance of the Pro318His variant is uncertain. -
Left ventricular noncompaction 1 Uncertain:1
Feb 24, 2023
New York Genome Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);Loss of glycosylation at P318 (P = 0.0517);.;